HCM
AGN

Highbridge Capital Management’s Allergan Inc AGN Stock Holding History

Highbridge Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-235,047
Closed -$50M – 1813
2014
Q4 		$50M Buy
235,047
+211,665
+905% +$42.1M 0.64% 32
2014
Q3 		$4.17M Sell
23,382
-75,872
-76% -$12.6M 0.06% 326
2014
Q2 		$16.8M Sell
99,254
-106,408
-52% -$16.6M 0.2% 130
2014
Q1 		$25.5M Buy
+205,662
New +$25M 0.32% 91
2013
Q4 		– Sell
-480,045
Closed -$43.4M – 1623
2013
Q3 		$43.4M Buy
480,045
+280,735
+141% +$25.2M 0.46% 46
2013
Q2 		$16.8M Buy
+199,310
New +$20.7M 0.17% 156

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Highbridge Capital Management's AGN Position: Q1 2015 in Review

Highbridge Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 235,047 shares — an estimated $50M sold.

Highbridge Capital Management first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $50M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Highbridge Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 235,047 Allergan Inc shares in Q1 2015, an estimated $50M.
  • Highbridge Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Highbridge Capital Management's Allergan Inc position peaked at $50M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Highbridge Capital Management's 13F filing for Q1 2015, filed 15 May 2015.